Lanreotide in Metastatic Enteropancreatic Neuroendocrine Tumors

10.1200/JCO.2007.15.4377

10.1016/j.ejca.2013.02.029

10.1056/NEJMoa1009290

10.1056/NEJMoa1003825

Kulke MH, 2012, J Natl Compr Canc Netw, 10, 724, 10.6004/jnccn.2012.0075

Oberg K, 2012, Ann Oncol, 23, vii124, 10.1093/annonc/mds295

10.1111/j.1365-2036.2011.04693.x

10.1093/annonc/mdi258

10.1186/1471-2407-13-427

10.1097/MEG.0b013e328359d1a6

10.1200/JCO.2009.22.8510

10.1093/jnci/92.3.205

Krenning EP, Kwekkeboom DJ, Pauwels S, Kvols LK, Reubi JC. Somatostatin receptor scintigraphy. In: Freeman LM, ed. Nuclear medicine annual. New York: Raven Press, 1995:1-5.

10.1097/00000421-198212000-00014

Rindi G, Arnold R. Nomenclature and classification of neuroendocrine neoplasms of the digestive system. In: Bosman F, Carneiro F, Hruban R, Theise N, eds. World Health Organization classification of tumours of the digestive system. Lyon, France: IARC Press, 2010:13-4.

10.1093/annonc/mdl105

10.1677/ERC-07-0288

10.1053/j.seminoncol.2012.11.006

10.1634/theoncologist.2011-0458

10.1159/000335597

10.1016/S0140-6736(11)61742-X

10.1200/JCO.2005.03.616

10.1200/JCO.2004.04.024

10.1200/JCO.2010.33.2056